The American College of Cardiology released a 2026 scientific statement on antiplatelet therapy for atherosclerotic cardiovascular disease.
Current guidelines recommend dual antiplatelet therapy, a combination of aspirin and a P2Y 12 inhibitor, for 6–12 months after percutaneous coronary intervention with drug-eluting stent implantation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results